OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma
Zhigang Ren, Ang Li, Jianwen Jiang, et al.
Gut (2018) Vol. 68, Iss. 6, pp. 1014-1023
Open Access | Times Cited: 596

Showing 1-25 of 596 citing articles:

A practical guide to amplicon and metagenomic analysis of microbiome data
Yongxin Liu, Yuan Qin, Tong Chen, et al.
Protein & Cell (2020) Vol. 12, Iss. 5, pp. 315-330
Open Access | Times Cited: 620

Altered microbiomes distinguish Alzheimer’s disease from amnestic mild cognitive impairment and health in a Chinese cohort
Ping Liu, Li Wu, Guoping Peng, et al.
Brain Behavior and Immunity (2019) Vol. 80, pp. 633-643
Open Access | Times Cited: 484

Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment
Federico Piñero, Melisa Dirchwolf, Mário G. Pessôa
Cells (2020) Vol. 9, Iss. 6, pp. 1370-1370
Open Access | Times Cited: 404

Advances in the early diagnosis of hepatocellular carcinoma
Weiyi Wang, Chao Wei
Genes & Diseases (2020) Vol. 7, Iss. 3, pp. 308-319
Open Access | Times Cited: 343

Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma
Jason Behary, Nadia Amorim, Xiaotao Jiang, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 313

Gut microbiome, liver immunology, and liver diseases
Rui Wang, Ruqi Tang, Bo Li, et al.
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 1, pp. 4-17
Open Access | Times Cited: 303

Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors
Daniel Q. Huang, Philippe Mathurin, Helena Cortez‐Pinto, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 1, pp. 37-49
Open Access | Times Cited: 277

Gut microbiome in HCC – Mechanisms, diagnosis and therapy
Robert F. Schwabe, Tim F. Greten
Journal of Hepatology (2020) Vol. 72, Iss. 2, pp. 230-238
Open Access | Times Cited: 275

A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease
Cyrielle Caussy, Anupriya Tripathi, Greg Humphrey, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 273

The mutual interplay of gut microbiota, diet and human disease
Placido Illiano, Roberta Brambilla, Cinzia Parolini
FEBS Journal (2020) Vol. 287, Iss. 5, pp. 833-855
Open Access | Times Cited: 266

The gut–liver axis and gut microbiota in health and liver disease
Cynthia L. Hsu, Bernd Schnabl
Nature Reviews Microbiology (2023) Vol. 21, Iss. 11, pp. 719-733
Closed Access | Times Cited: 243

Gut microbiome, big data and machine learning to promote precision medicine for cancer
Giovanni Cammarota, Gianluca Ianiro, Anna M. Ahern, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 10, pp. 635-648
Closed Access | Times Cited: 242

Alterations in the human oral and gut microbiomes and lipidomics in COVID-19
Zhigang Ren, Haiyu Wang, Guangying Cui, et al.
Gut (2021) Vol. 70, Iss. 7, pp. 1253-1265
Open Access | Times Cited: 230

Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome
Ziying Zhang, Haosheng Tang, Peng Chen, et al.
Signal Transduction and Targeted Therapy (2019) Vol. 4, Iss. 1
Open Access | Times Cited: 209

Specific gut microbiome signature predicts the early-stage lung cancer
Yajuan Zheng, Zhaoyuan Fang, Yun Xue, et al.
Gut Microbes (2020) Vol. 11, Iss. 4, pp. 1030-1042
Open Access | Times Cited: 203

Microecological Koch’s postulates reveal that intestinal microbiota dysbiosis contributes to shrimp white feces syndrome
Zhijian Huang, Shenzheng Zeng, Jinbo Xiong, et al.
Microbiome (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 183

Identification of microbial markers across populations in early detection of colorectal cancer
Yuanqi Wu, Na Jiao, Ruixin Zhu, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 171

Dysbiosis of human gut microbiome in young-onset colorectal cancer
Yongzhi Yang, Lutao Du, Debing Shi, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 164

Alteration in gut microbiota associated with hepatitis B and non-hepatitis virus related hepatocellular carcinoma
Qisha Liu, Fan Li, Yaoyao Zhuang, et al.
Gut Pathogens (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 163

Gut microbiome composition may be an indicator of preclinical Alzheimer’s disease
Aura Ferreiro, JooHee Choi, Jian Ryou, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 700
Open Access | Times Cited: 159

From correlation to causality: the case of Subdoligranulum
Matthias Van Hul, Tiphaine Le Roy, Edi Prifti, et al.
Gut Microbes (2020) Vol. 12, Iss. 1, pp. 1849998-1849998
Open Access | Times Cited: 155

Oral–Gut Microbiome Axis in Gastrointestinal Disease and Cancer
Se-Young Park, Byeong-Oh Hwang, Mihwa Lim, et al.
Cancers (2021) Vol. 13, Iss. 9, pp. 2124-2124
Open Access | Times Cited: 155

Gut Microbiota Changes in Patients with Bipolar Depression
Shaohua Hu, Ang Li, Tingting Huang, et al.
Advanced Science (2019) Vol. 6, Iss. 14
Open Access | Times Cited: 146

Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure
Jonel Trebicka, Peer Bork, Aleksander Krag, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 18, Iss. 3, pp. 167-180
Closed Access | Times Cited: 145

Page 1 - Next Page

Scroll to top